Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Switching From Protease Inhibitor (PI) to Etravirine in HIV-1 Infected Subjects With Viremia Suppression

This study has been completed.
Information provided by (Responsible Party):
Dra. EUGENIA NEGREDO PUIGMAL, Fundacio Lluita Contra la SIDA Identifier:
First received: December 17, 2009
Last updated: October 24, 2012
Last verified: July 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2011
  Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):